Inspire Investing LLC Makes New Investment in Globe Life Inc. $GL

Key Points

• Inspire Investing LLC has acquired a stake of 6,048 shares in Globe Life Inc. (NYSE:GL), valued at approximately $797,000, during the first quarter of the year.
• Insider transactions reveal that CFO Thomas Peter Kalmbach sold 28,952 shares, resulting in a 48.56% decrease in his ownership, which could raise concerns regarding internal confidence in the company's future.
• Analysts project a favorable outlook for Globe Life, with several upgrades, increasing price targets, and a consensus rating of "Moderate Buy."

Inspire Investing LLC acquired a new position in shares of Globe Life Inc. (NYSE:GL - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 6,048 shares of the company's stock, valued at approximately $797,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in GL. Principal Financial Group Inc. increased its holdings in shares of Globe Life by 4.1% in the first quarter. Principal Financial Group Inc. now owns 101,679 shares of the company's stock worth $13,393,000 after acquiring an additional 3,960 shares in the last quarter. DAVENPORT & Co LLC bought a new stake in Globe Life during the 1st quarter worth approximately $493,000. Atlas Capital Advisors Inc. bought a new stake in Globe Life during the 1st quarter worth approximately $893,000. Sequoia Financial Advisors LLC raised its holdings in Globe Life by 693.4% during the 1st quarter. Sequoia Financial Advisors LLC now owns 24,184 shares of the company's stock worth $3,185,000 after buying an additional 21,136 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Globe Life by 8.0% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 9,711 shares of the company's stock valued at $1,260,000 after buying an additional 723 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Cfra Research upgraded shares of Globe Life to a "moderate buy" rating in a report on Friday, July 25th. Keefe, Bruyette & Woods increased their target price on Globe Life from $145.00 to $155.00 and gave the stock an "outperform" rating in a report on Monday, July 28th. BMO Capital Markets restated a "market perform" rating and issued a $149.00 price target (up from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. JPMorgan Chase & Co. upped their price objective on Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 8th. Finally, Truist Financial began coverage on Globe Life in a research report on Tuesday, July 15th. They issued a "buy" rating and a $150.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Globe Life presently has a consensus rating of "Moderate Buy" and a consensus price target of $152.45.

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of the stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the transaction, the chief executive officer owned 32,747 shares in the company, valued at $4,629,770.86. This represents a 27.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO James Matthew Darden sold 33,270 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $135.59, for a total value of $4,511,079.30. Following the sale, the chief executive officer directly owned 49,842 shares in the company, valued at $6,758,076.78. This represents a 40.03% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 84,722 shares of company stock worth $11,733,793. 1.51% of the stock is currently owned by company insiders.

Globe Life Stock Performance

Shares of Globe Life stock traded up $1.62 on Thursday, hitting $144.42. The stock had a trading volume of 156,500 shares, compared to its average volume of 632,295. The stock has a market cap of $11.70 billion, a price-to-earnings ratio of 11.54 and a beta of 0.56. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a twelve month low of $100.27 and a twelve month high of $144.45. The business's 50 day moving average is $135.75 and its two-hundred day moving average is $127.06.

Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period in the prior year, the firm posted $2.97 EPS. The company's revenue for the quarter was up 2.9% on a year-over-year basis. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Analysts forecast that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.7%. Globe Life's payout ratio is currently 8.63%.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.